Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Taikang Asset

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 11
Average round size
info
The average size of a deal this fund participated in
$197M
Portfolio companies 11
Rounds per year 0.69
Lead investments 3
Exits 1
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Education
  • Manufacturing
Summary

In 2006 was created Taikang Asset, which is appeared as VC. The main department of described VC is located in the Beijing. The company was established in Asia in China.

The overall number of key employees were 1.

The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Taikang Asset, startups are often financed by Lilly Asia Ventures, ARCH Venture Partners, Merck. The meaningful sponsors for the fund in investment in the same round are TiAN, Temasek Holdings, Lilly Asia Ventures.

Among the most successful fund investment fields, there are Car Sharing, Biotechnology. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the various public portfolio startups of the fund, we may underline Shouqi Car Rental, Hangzhou Just Biotherapeutics (Just China)

The real fund results show that this VC is 47 percentage points more often commits exit comparing to other companies. Deals in the range of more than 100 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Taikang Asset works on 4 percentage points more the average amount of lead investments. The important activity for fund was in 2019. The top amount of exits for fund were in 2019.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Taikang Asset:
Typical Co-investors
Taikang Asset is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Taikang Asset:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BlueIO Burlington, Massachusetts, United States
Brain Trust Accelerator Fund Burlingame, California, United States
Bright Stone Beijing, Beijing, China
eCompanies California, Santa Monica, United States
Finaccess Capital Distrito Federal, Mexico, Mexico City
Hekikai Shinkin Bank Aichi Prefecture, Anjo, Japan
Huayi Ziben China, Jiading District
Iterative Central, Central Region, Singapore
Kawawa Capital -
KnowledgeSuite Japan, Tokyo
Kotak Private Equity -
Magnesium Capital England, London, United Kingdom
PYN Fund Management Finland, Helsinki, Southern Finland
RECAPEX Stockholm, Stockholm County, Sweden
Shanghai Atlantic Investment China, Shanghai
The Colorado Impact Fund Colorado, Denver, United States
Tokio Marine Nichido Dubai, United Arab Emirates
Walker Ventures Glenwood, Maryland, United States
Zobito Malmo, Skåne County, Sweden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Svolt Energy Technology Co.

Battery
Electric Vehicle
Energy
Energy Storage
Manufacturing
$927M13 Dec 2021 Baoding City, Hebei, China

Dreame Technology

Electronics
Manufacturing
$556M21 Oct 2021 Gusu District, Jiangsu, China

Orient Speech Therapy Center

Education
Language Learning
Speech Recognition
$60M25 Jun 2021 China, Beijing, China

GensKey

Health Care
Medical
$15M01 Jun 2021 Dongcheng District, Beijing, China

Health Care
$15M29 Apr 2019 China, Shanghai

Hangzhou Just Biotherapeutics (Just China)

Biopharma
Biotechnology
Medical
Pharmaceutical
$35M06 Jun 2018 China, Zhejiang

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Taikang Asset?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 11
Average round size 197M
Rounds per year 0.69
Peak activity year 2021
Lead investments 3
Exits 1
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Svolt Energy Technology Co.

Battery
Electric Vehicle
Energy
Energy Storage
Manufacturing
$927M13 Dec 2021 Baoding City, Hebei, China

Dreame Technology

Electronics
Manufacturing
$556M21 Oct 2021 Gusu District, Jiangsu, China

Orient Speech Therapy Center

Education
Language Learning
Speech Recognition
$60M25 Jun 2021 China, Beijing, China

GensKey

Health Care
Medical
$15M01 Jun 2021 Dongcheng District, Beijing, China

Health Care
$15M29 Apr 2019 China, Shanghai

Hangzhou Just Biotherapeutics (Just China)

Biopharma
Biotechnology
Medical
Pharmaceutical
$35M06 Jun 2018 China, Zhejiang
Crunchbase icon

Content report

The following text will be sent to our editors: